KIR2DS2 Peptide - N-terminal region

Aviva Systems Biology

KIR2DS2 Peptide - N-terminal region

23

Western Blot

Research Use Only

Lyophilized powder

KIR2DS2

killer cell immunoglobulin like receptor, two Ig domains and short cytoplasmic tail 2

183ActI, CD158J, CD158b, KIR-2DS2, KIR2DL1, NKAT-5, NKAT5, cl-49, killer cell immunoglobulin-like receptor 2DS2, CD158 antigen-like family member J, KIR2DS2 Killer-cell Immunoglobulin-like Receptor, MHC class I NK cell receptor, NK receptor 183 ActI, killer cell immunoglobulin-like receptor KIR2DS2, killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2, killer-cell Ig-like receptor, killer-cell immunoglobulin-like receptor two domains short tail 2 protein, natural killer associated transcript 5, natural killer cell inhibitory receptor, p58 killer cell inhibitory receptor KIR-K7a, p58 natural killer cell receptor clone CL-49

This is a synthetic peptide designed for use in combination with anti-KIR2DS2 Antibody (ARP63891_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

41116100

Human